5/17
04:05 pm
acad
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/15
09:13 am
acad
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome [Yahoo! Finance]
5/15
09:05 am
acad
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
Low
Report
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
5/11
09:34 am
acad
Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
Low
Report
Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
5/10
08:22 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Bank of America Co. from $26.00 to $22.00. They now have a "neutral" rating on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Bank of America Co. from $26.00 to $22.00. They now have a "neutral" rating on the stock.
5/9
05:07 pm
acad
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences [Yahoo! Finance]
5/9
04:58 pm
acad
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Low
Report
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
5/9
03:48 pm
acad
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
03:40 pm
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at HC Wainwright from $33.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at HC Wainwright from $33.00 to $27.00. They now have a "buy" rating on the stock.
5/9
02:05 pm
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
5/9
10:11 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Stifel Nicolaus from $26.00 to $21.00. They now have a "hold" rating on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Stifel Nicolaus from $26.00 to $21.00. They now have a "hold" rating on the stock.
5/9
10:11 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
5/9
08:17 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Robert W. Baird from $31.00 to $28.00. They now have an "outperform" rating on the stock.
High
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Robert W. Baird from $31.00 to $28.00. They now have an "outperform" rating on the stock.
5/9
08:17 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
High
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
5/9
08:17 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Mizuho from $25.00 to $21.00. They now have a "neutral" rating on the stock.
High
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Mizuho from $25.00 to $21.00. They now have a "neutral" rating on the stock.
5/9
07:40 am
acad
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss [Yahoo! Finance]
Medium
Report
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss [Yahoo! Finance]
5/8
04:12 pm
acad
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview [Yahoo! Finance]
High
Report
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview [Yahoo! Finance]
5/8
04:05 pm
acad
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
High
Report
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
5/6
08:05 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $19.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $19.00 price target on the stock.
4/30
10:27 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
4/29
04:24 pm
acad
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship [Yahoo! Finance]
4/29
04:16 pm
acad
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
Low
Report
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
4/28
09:56 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago [Yahoo! Finance]
Medium
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago [Yahoo! Finance]
4/24
04:14 pm
acad
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 [Yahoo! Finance]
4/24
04:05 pm
acad
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
Low
Report
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024